• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何充分利用昂贵的巴雷特食管监测。

How to get the most out of costly Barrett's oesophagus surveillance.

机构信息

Translation Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Translation Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

出版信息

Dig Liver Dis. 2018 Sep;50(9):871-877. doi: 10.1016/j.dld.2018.04.012. Epub 2018 Apr 22.

DOI:10.1016/j.dld.2018.04.012
PMID:29730158
Abstract

Current endoscopic surveillance protocols for Barrett's oesophagus have several limitations, mainly the poor cost-effectiveness and high miss rate. However, there is sufficient evidence that patients enrolled in a surveillance program have better survival chances of oesophageal cancer due to earlier tumor stages at diagnosis compared to patients with de novo diagnosed oesophagus cancer. Risk stratifications aim to identify patients at highest risk of developing adenocarcinoma of the oesophagus; most of them base on the length of the Barrett's segment and the presence of dysplasia. This review discusses prognostic factors and provides practical guidance on how to improve the efficacy and outcome in Barrett's surveillance programs.

摘要

目前 Barrett 食管的内镜监测方案存在一些局限性,主要是成本效益差和高漏诊率。然而,有充分的证据表明,与新诊断的食管癌患者相比,参加监测计划的患者由于诊断时肿瘤分期更早,因此具有更好的食管癌生存机会。风险分层旨在确定患食管腺癌风险最高的患者;其中大多数基于 Barrett 段的长度和异型增生的存在。本文讨论了预后因素,并就如何提高 Barrett 监测计划的效果和结果提供了实用指导。

相似文献

1
How to get the most out of costly Barrett's oesophagus surveillance.如何充分利用昂贵的巴雷特食管监测。
Dig Liver Dis. 2018 Sep;50(9):871-877. doi: 10.1016/j.dld.2018.04.012. Epub 2018 Apr 22.
2
Barrett's oesophagus: Current controversies.巴雷特食管:当前的争议。
World J Gastroenterol. 2017 Jul 28;23(28):5051-5067. doi: 10.3748/wjg.v23.i28.5051.
3
[Surveillance for Barrett's oesophagus: worthwhile?].[巴雷特食管的监测:是否值得?]
Ned Tijdschr Geneeskd. 2012;156(49):A5497.
4
Are screening and surveillance for Barrett's oesophagus really worthwhile?对巴雷特食管进行筛查和监测真的值得吗?
Gut. 2005 Mar;54 Suppl 1(Suppl 1):i27-32. doi: 10.1136/gut.2004.041566.
5
Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?巴雷特食管的筛查和监测:是否具有成本效益?
Dig Dis Sci. 2018 Aug;63(8):2094-2104. doi: 10.1007/s10620-018-5148-7.
6
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.英国胃肠病学会 Barrett 食管诊断和管理指南。
Gut. 2014 Jan;63(1):7-42. doi: 10.1136/gutjnl-2013-305372. Epub 2013 Oct 28.
7
Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.实施巴雷特食管筛查与监测策略的成本考量
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):51-63. doi: 10.1016/j.bpg.2014.12.002. Epub 2014 Dec 18.
8
Barrett's oesophagus: epidemiology, cancer risk and implications for management.巴雷特食管:流行病学、癌症风险及管理意义。
Gut. 2014 Jan;63(1):191-202. doi: 10.1136/gutjnl-2013-305490. Epub 2013 Oct 3.
9
Advanced imaging in surveillance of Barrett's esophagus: Is the juice worth the squeeze?巴雷特食管监测中的高级影像学:是否物有所值?
World J Gastroenterol. 2019 Jul 7;25(25):3108-3115. doi: 10.3748/wjg.v25.i25.3108.
10
A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.大多数巴雷特食管患者不太可能从内镜癌症监测中获益。
Eur J Gastroenterol Hepatol. 2001 Jun;13(6):639-45. doi: 10.1097/00042737-200106000-00005.

引用本文的文献

1
Highlighting the Undetectable - Fluorescence Molecular Imaging in Gastrointestinal Endoscopy.突出不可见的部分 - 荧光分子内镜成像在胃肠道内镜中的应用。
Mol Imaging Biol. 2023 Feb;25(1):18-35. doi: 10.1007/s11307-022-01741-1. Epub 2022 Jun 28.
2
Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.中性粒细胞与淋巴细胞比值作为非异型增生 Barrett 食管进展为食管腺癌的标志物:一项横断面回顾性研究。
J Gastrointest Surg. 2020 Jan;24(1):8-18. doi: 10.1007/s11605-019-04456-x. Epub 2019 Nov 19.